You can:
Name | 5-hydroxytryptamine receptor 2A |
---|---|
Species | Homo sapiens (Human) |
Gene | HTR2A |
Synonym | 5-HT-2 serotonin receptor 2A serotonin 5HT-2 receptor 5-HT-2A 5-HT2A receptor [ Show all ] |
Disease | Depression Unspecified Diabetes Erythropoietic porphyria Fibromyalgia [ Show all ] |
Length | 471 |
Amino acid sequence | MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV |
UniProt | P28223 |
Protein Data Bank | 6a93, 6a94 |
GPCR-HGmod model | P28223 |
3D structure model | This structure is from PDB ID 6a93. |
BioLiP | BL0441025,BL0441028, BL0441031, BL0441030,BL0441033, BL0441029,BL0441032, BL0441026, BL0441024,BL0441027 |
Therapeutic Target Database | T32060 |
ChEMBL | CHEMBL224 |
IUPHAR | 6 |
DrugBank | BE0000451 |
Name | olanzapine |
---|---|
Molecular formula | C17H20N4S |
IUPAC name | 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine |
Molecular weight | 312.435 |
Hydrogen bond acceptor | 4 |
Hydrogen bond donor | 1 |
XlogP | 2.9 |
Synonyms | 2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine HMS3657I15 2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine S-4287 Jsp001969 [ Show all ] |
Inchi Key | KVWDHTXUZHCGIO-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3 |
PubChem CID | 135398745 |
ChEMBL | CHEMBL715 |
IUPHAR | N/A |
BindingDB | 35254 |
DrugBank | DB00334 |
Structure | ![]() |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
N/A | N/A | DrugBank | |
IC50 | 5.016 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
IC50 | 7.0 nM | PMID23466228 | BindingDB |
IC50 | 7.0 nM | PMID23466228 | ChEMBL |
IC50 | 9.0 nM | PMID8831770 | BindingDB,ChEMBL |
IC50 | 100.0 nM | PMID26227779 | BindingDB,ChEMBL |
Ki | 1.433 nM | DrugMatrix in vitro pharmacology data | ChEMBL |
Ki | 1.585 nM | PMID17880057 | ChEMBL |
Ki | 1.9 nM | PMID14998318, PMID11170639 | BindingDB,ChEMBL |
Ki | 2.3 nM | PMID15771415 | BindingDB,ChEMBL |
Ki | 2.5 nM | , PMID24559051, None | BindingDB,ChEMBL |
Ki | 3.3 nM | PMID18595716, PMID25070422 | BindingDB,ChEMBL |
Ki | 4.0 nM | PMID23466228, PMID25343529, PMID19836247, PMID8831770 | BindingDB,ChEMBL |
Ki | 4.0 nM | PMID23466228, PMID25343529 | BindingDB |
Ki | 100.0 nM | MedChemComm, (2012) 3:5:580 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417